These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 29524309)
1. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25. Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309 [TBL] [Abstract][Full Text] [Related]
2. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer. Shahabi A; Naghili B; Ansarin K; Montazeri M; Dadashpour M; Zarghami N Asian Pac J Cancer Prev; 2021 Jan; 22(1):305-313. PubMed ID: 33507713 [TBL] [Abstract][Full Text] [Related]
3. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2. Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542 [TBL] [Abstract][Full Text] [Related]
4. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4. Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling. Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer. Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer. Sun G; Liu M; Han H J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1. Zhao C; Ling X; Li X; Hou X; Zhao D Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644 [TBL] [Abstract][Full Text] [Related]
9. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464 [TBL] [Abstract][Full Text] [Related]
10. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα. Xin H; Wang C; Liu Z BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136 [TBL] [Abstract][Full Text] [Related]
13. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer. Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2. He J; Wang J; Li S; Li T; Chen K; Zhang S Cancer Sci; 2020 Oct; 111(10):3550-3563. PubMed ID: 32726486 [TBL] [Abstract][Full Text] [Related]
15. MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7. Xiao Y; Zhang SJ; Yan X; Wu C; Liu QW; Dong HX; Wang LJ; Hu Y Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5625-5635. PubMed ID: 34604955 [TBL] [Abstract][Full Text] [Related]
16. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells. Wang C; Xie XX; Li WJ; Jiang DQ Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195 [TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway. Wang J; Liang S; Duan X J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition. Song R; Zhang J; Huang J; Hai T Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220 [TBL] [Abstract][Full Text] [Related]
19. MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4. Zhao X; Dai L; Yue Q; Wang H; Wang XU; Li Y; Chen R J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894127 [TBL] [Abstract][Full Text] [Related]
20. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin. Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]